SEARCH

SEARCH BY CITATION

References

  • Bury, M. (1982) Chronic illness as biographical disruption, Sociology of Health and Illness, 4, 2, 16782.
  • Carricaburu, D. and Pierret, J. (1995) From biographical disruption to biographical reinforcement: the case of HIV-positive men, Sociology of Health and Illness, 17, 1, 6588.
  • Conrad, P. and Gabe, J. (1999) Introduction: sociological perspectives on the new genetics, Sociology of Health & Illness, 21, 5, 50516.
  • Cox, S. and McKellin, W. (1999) ‘There’s this thing in our family’: predictive testing and the construction of risk for Huntington Disease, Sociology of Health & Illness, 21, 5, 62246.
  • Crossley, N. (1995) Body techniques, agency and intercorporeality: on Goffman’s relations in public, Sociology, 29, 1, 13349.
  • Crossley, N. (1997) Corporeality and communicative action: embodying the renewal of critical theory, Body and Society, 3, 1, 1746.
  • Datta, B., McDowell, I. and Rees, A. (2010) Integrating provision of specialist lipid services with cascade testing for familial hypercholesterolaemia, Current Opinion in Lipidology, 21, 4, 36671.
  • Davison, C., Frankel, S. and Davey Smith, G. (1989) Inheriting heart trouble: the relevance of common-sense ideas to preventative measures, Health Education Research, 4, 3, 32940.
  • DeMott, K., Nherera, L., Shaw, E., Minhas, R., et al. (2008) Clinical Guidelines and Evidence Review for Familial Hypercholesterolaemia: The Identification and Management of Adults and Children with Familial Hypercholesterolaemia. London: National Collaborating Centre for Primary Care and Royal College of General Practitioners.
  • Emslie, C., Hunt, K. and Watt, G. (2003) A chip off the old block? Lay understandings of inheritance among men and women in mid-life, Public Understanding of Science, 12, 1, 4765.
  • Featherstone, K., Atkinson, P., Bharadwaj, A. and Clarke, A. (2006) Risky Relations: Family, Kinship and the New Genetics. Oxford: Berg.
  • Finkler, K. (2000) Experiencing the New Genetics. Family and Kinship on the Medical Frontier. Philadelphia: University of Pennsylvania Press.
  • Finnie, R. (2010) Cascade screening for familial hypercholesterolaemia in Scotland, British Journal of Diabetes and Vascular Disease, 10, 3, 1235.
  • Foucault, M. (1973) The Birth of the Clinic: An Archaeology of Medical Perception. London: Tavistock.
  • Hallowell, N. (1999) Doing the right thing: genetic risk and responsibility, Sociology of Health & Illness, 21, 5, 597621.
  • Hallowell, N., Foster, C., Ardern-Jones, A., Eeles, R., et al. (2002) Genetic testing for women previously diagnosed with breast/ovarian cancer: explaining the impact of BRCA1 and BRCA2 mutation searching, Genetic Testing, 6, 2, 7987.
  • Hallowell, N., Jenkins, N., Douglas, M., Walker, S., et al. (2011) Patients’ experiences and views of cascade screening for familial hypercholesterolemia (FH): a qualitative study, Journal of Community Genetics, 2, 4, 24957.
  • Howson, A. (1998) Embodied obligation: the female body and health surveillance. In Nettleton, S. and Watson, J. (eds) The Body in Everyday Life. London and New York: Routledge.
  • Hubbard, G., Kidd, L. and Kearney, N. (2010) Disrupted lives and threats to identity: the experiences of people with colorectal cancer within the first year following diagnosis, Health, 14, 2, 13146.
  • Humphries, S., Cranston, T., Allen, M., Middleton-Price, H., et al. (2006) Mutational analysis in UK patients with a clinical diagnosis of familial hypercholesterolaemia: relationship with plasma lipid traits, heart disease risk and utility in relative tracing, Journal of Molecular Medicine, 84, 3, 20314.
  • Jenkins, N., Lawton, J., Douglas, M., Walker, S., et al. (2011) How do index patients participating in genetic screening programmes for familial hypercholesterolemia (FH) interpret their DNA results? A UK-based qualitative interview study, Patient Education and Counselling, DOI: 10.1016/j.pec.2011.09.002.
  • Kenen, R. (1994) The human genome project: creator of the potentially sick, potentially vulnerable and potentially stigmatized? In Robinson, I. (ed.) Life and Death Under High Technology Medicine. Manchester: Manchester University Press.
  • Kerr, A. (2004) Genetics and Society: A Sociology of Disease. London and New York: Routledge.
  • Lawton, J. (2003) Lay experiences of health and illness: past research and future agendas, Sociology of Health & Illness, 25, 3, 2340.
  • Lawton, J. (2000) The Dying Process: Patients’ Experiences of Palliative Care. London and New York: Routledge.
  • Leren, T. (2004) Cascade genetic screening for familial hypercholesterolemia, Clinical Genetics, 66, 6, 483487.
  • Leren, T., Manshaus, T., Skovholt, U., Skodje, T., et al. (2004) Application of molecular genetics for diagnosing familial hypercholesterolemia in Norway: results from a family-based screening program, Seminars in Vascular Medicine, 4, 1, 7585.
  • Marks, D., Thorogood, M., Farrer, J. and Humphries, S. (2004) Census of clinics providing specialist lipid services in the United Kingdom, Journal of Public Health, 26, 4, 3534.
  • Merleau-Ponty, M. (1968) The Visible and the Invisible: Followed by Working Notes. Evanston: Northwestern University Press.
  • Neil, H., Hammond, T., Huxley, R., Matthews, D., et al. (2000) Extent of underdiagnosis of familial hypercholesterolaemia in routine practice: prospective registry study, British Medical Journal, 321, 7254, 148.
  • Novas, C. and Rose, N. (2000) Genetic risk and the birth of the somatic individual, Economy and Society, 29, 4, 485513.
  • Pedersen, K., Humphries, S., Roughton, M. and Besford, J. (2010) National Clinical Audit of the Management of Familial Hypercholesterolaemia 2010: Full Report. London: Clinical Standards Department: Royal College of Physicians.
  • Pocovi, M., Civeira, F., Alonso, R. and Mata, P. (2004) Familial hypercholesterolemia in Spain: case-finding program, clinical and genetic aspects, Seminars in Vascular Medicine, 4, 1, 6774.
  • Priest, S. (1998) Merleau-Ponty. London and New York: Routledge.
  • Radley, A. (1989) Style, discourse and constraint in adjustment to chronic illness, Sociology of Health & Illness, 11, 3, 23052.
  • Scientific Steering Committee on behalf of the Simon Broome Register Group (1991) Risk of fatal coronary heart disease in familial hypercholesterolaemia, British Medical Journal, 303, 6807, 8936.
  • Slack, J. (1969) Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states, Lancet, 2, 7635, 13802.
  • Springgay, S. (2008) Body Knowledge and Curriculum: Pedagogies of Touch in Youth and Visual Culture. New York: Peter Lang.
  • Strauss, A. and Corbin, J. (1990) Basics of Qualitative Research: Grounded Theory Procedures and Techniques. London: Sage.
  • Umans-Eckenhausen, M., Defesche, J., Sijbrands, E., Scheerder, R., et al. (2001) Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands, Lancet, 357, 9251, 165168.
  • Walter, F., Emery, J., Braithwaite, D. and Marteau, T. (2004) Lay understanding of familial risk of common chronic diseases: a systematic review and synthesis of qualitative research, Annals of Family Medicine, 2, 6, 583594.
  • Weiner, K. (2009) The tenacity of the coronary candidate: how people with familial hypercholesterolaemia construct raised cholesterol and coronary heart disease, Health, 13, 4, 407427.
  • Weiner, K. (2011) Exploring genetic responsibility for the self, family and kin in the case of hereditary raised cholesterol, Social Science & Medicine, 72, 11, 17607.
  • Weiss, G. (1999) Body Images: Embodiment as Intercorporeality. London and New York: Routledge
  • Will, C., Armstrong, D. and Marteau, T. (2010) Genetic unexceptionalism: clinician accounts of genetic testing for familial hypercholesterolaemia, Social Science & Medicine, 71, 5, 91017.
  • Wilson, S. (2007) ‘When you have children, you’re obliged to live’: motherhood, chronic illness and biographical disruption, Sociology of Health & Illness, 29, 4, 61026.